Breakthrough SARS-CoV-2 infections among patients with cancer following two and three doses of COVID-19 mRNA vaccines: a retrospective observational study from the COVID-19 and Cancer Consortium.
Published in Lancet regional health. Americas • Mar 1, 2023
Authors:,,
Toni K Choueiri
Chris Labaki
Ziad Bakouny
Abstract
Background: Breakthrough SARS-CoV-2 infections following vaccination against COVID-19 are of international concern. Patients with cancer have been observed to have worse outcomes associated with COVID-19 during the pandemic. We sought to evaluate the clinical characteristics and outcomes of patients...
Finding related papers...
Discussions
(0)No comments yet
Be the first to share your thoughts!